Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma

Anti-VEGF drugs, such as tyrosine kinase inhibitors, play an important role in systemic therapy for unresectable hepatocellular carcinoma (uHCC). We examined the effects of sorafenib and lenvatinib on proteinuria and renal function. Patients who were administered sorafenib (n = 85) or lenvatinib (n ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Ryu, Fukushima, Masanori, Haraguchi, Masafumi, Honda, Takuya, Miuma, Satoshi, Miyaaki, Hisamitsu, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276219/
https://www.ncbi.nlm.nih.gov/pubmed/35583540
http://dx.doi.org/10.1097/MD.0000000000029289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276219/
https://www.ncbi.nlm.nih.gov/pubmed/35583540
http://dx.doi.org/10.1097/MD.0000000000029289

Ejemplares similares